Copyright
©The Author(s) 2022.
World J Gastrointest Surg. Nov 27, 2022; 14(11): 1260-1271
Published online Nov 27, 2022. doi: 10.4240/wjgs.v14.i11.1260
Published online Nov 27, 2022. doi: 10.4240/wjgs.v14.i11.1260
Table 1 Patient baseline characteristics
| Characteristic | Count (%) |
| Male | 59 (59.00) |
| Age | 58.48 ± 13.90 |
| Etiology | |
| Hepatitis B related CLD | 38 (38.00) |
| Hepatitis C related CLD | 3 (3.00) |
| Schistosome related CLD | 16 (16.00) |
| Autoimmune liver disease | 14 (14.00) |
| Alcoholic liver disease | 5 (5.00) |
| Liver tumors | 14 (14.00) |
| Drug induced CLD | 2 (2.00) |
| Liver abscess | 1 (1.00) |
| Chronic liver failure | 1 (1.00) |
| Budd Chiari syndrome | 1 (1.00) |
| CLD of unknown origin | 5 (5.00) |
| Child-Pugh grades | |
| Grade A (5-6 points) | 8 (8.00) |
| Grade B (7-9 points) | 48 (48.00) |
| Grade C (10-15 points) | 44 (44.00) |
| Different platelet counts (× 109/L) | |
| Group I (< 30) | 25 (25.00) |
| Group II (30-50) | 43 (43.00) |
| Group III (> 50) | 32 (32.00) |
| Medication duration | |
| Group A ( 7 d) | 31 (31.00) |
| Group B (8-14 d) | 38 (38.00) |
| Group C (15-21 d) | 22 (22.00) |
| Group D (22-28 d) | 9 (9.00) |
| No platelet transfusion | 90 (90.00) |
| Side effect | |
| Fever | 2 (2.00) |
| Fatigue and anorexia | 4 (4.00) |
- Citation: Ding JN, Feng TT, Sun W, Cai XY, Zhang Y, Zhao WF. Recombinant human thrombopoietin treatment in patients with chronic liver disease-related thrombocytopenia undergoing invasive procedures: A retrospective study. World J Gastrointest Surg 2022; 14(11): 1260-1271
- URL: https://www.wjgnet.com/1948-9366/full/v14/i11/1260.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v14.i11.1260